# XERAVA
> **NDA211109** · New Drug Application · Sponsor: TETRAPHASE PHARMS · Approved 2018-08-27
## Drug
- **FDA Application Number:** NDA211109
- **Application type:** New Drug Application
- **Brand name:** XERAVA
- **Generic name:** ERAVACYCLINE
- **Active ingredients:** ERAVACYCLINE DIHYDROCHLORIDE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** TETRAPHASE PHARMS
- **Manufacturer:** Tetraphase Pharmaceuticals, Inc.
- **First approval:** 2018-08-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211109)
---
*MORVS · CC0 1.0*